GALFO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 167
EU - Europa 116
AS - Asia 56
AF - Africa 14
SA - Sud America 6
OC - Oceania 1
Totale 360
Nazione #
US - Stati Uniti d'America 167
IT - Italia 52
SG - Singapore 33
SE - Svezia 27
DE - Germania 14
CN - Cina 9
BG - Bulgaria 8
CI - Costa d'Avorio 8
GB - Regno Unito 6
IN - India 5
SN - Senegal 5
CZ - Repubblica Ceca 4
VN - Vietnam 4
CO - Colombia 2
FI - Finlandia 2
HK - Hong Kong 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
EG - Egitto 1
HU - Ungheria 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 360
Città #
Chandler 36
Florence 16
Boardman 13
New York 11
Singapore 11
Fairfield 10
Frankfurt am Main 9
Abidjan 8
Sofia 8
Kent 7
Ogden 7
Houston 6
Wilmington 6
Dakar 5
Lawrence 5
London 5
Princeton 5
Medford 4
Vicopisano 4
Ashburn 3
Brno 3
Hyderabad 3
Milan 3
Munich 3
Pisa 3
Seattle 3
Ann Arbor 2
Bolzano 2
Bremen 2
Brescello 2
Catania 2
Dallas 2
Hanoi 2
Hong Kong 2
Lima 2
Livorno 2
Los Angeles 2
Rome 2
Terranuova Bracciolini 2
Atlanta 1
Bologna 1
Brdo 1
Budapest 1
Cairo 1
Cambridge 1
Cascina 1
Charlotte 1
Dong Ket 1
Dubai 1
Helsinki 1
Istanbul 1
Kraljevo 1
La Plata 1
Lanuvio 1
Lappeenranta 1
Manizales 1
Messina 1
Phoenix 1
Pontedera 1
Prescot 1
Quezon City 1
Redwood City 1
San Diego 1
Serra 1
Stockholm 1
Sydney 1
Washington 1
Woodbridge 1
Totale 252
Nome #
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales 60
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 58
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study 56
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 50
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 50
Clinical features and outcomes of infections caused by metallo-β-lactamases producing Enterobacterales: a 3-year prospective study from an endemic area 20
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 18
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 17
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 15
Pharyngeal and cutaneous diphtheria: a tail of a refugee 9
Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization 8
Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital 6
What is the clinical significance of 'heteroresistance' in nonfermenting Gram-negative strains? 6
Totale 373
Categoria #
all - tutte 2.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 2 13 0 6 1 0 3
2021/202247 2 4 0 0 5 6 3 4 1 2 7 13
2022/2023146 11 16 7 10 17 14 7 12 34 0 18 0
2023/2024110 4 3 12 0 14 14 8 0 2 6 29 18
2024/202545 13 19 10 3 0 0 0 0 0 0 0 0
Totale 373